Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Dec;83(12):1332–1335. doi: 10.1136/bjo.83.12.1332

Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area

K Chern 1, S Shrestha 1, V Cevallos 1, H Dhami 1, P Tiwari 1, L Chern 1, J Whitcher 1, T Lietman 1
PMCID: PMC1722897  PMID: 10574809

Abstract

BACKGROUND/AIMS—The World Health Organisation has recommended repeated mass treatment of children in trachoma endemic areas with oral azithromycin. While chlamydia, the causative agent of trachoma, remains universally sensitive to azithromycin, there is concern that large scale programmes may alter the bacterial flora and induce resistance in streptococcal species. In this study the effect of a single dose of azithromcyin on the prevalence, species distribution, and resistance of conjunctival bacterial flora was determined.
METHODS—Baseline and 14 day follow up bacterial cultures were taken from the conjunctivae of 121 children who reside in a trachoma endemic area of Nepal. 91 children were treated with azithromycin at baseline and 31 children received deferred treatment at the 14 day follow up.
RESULTS—Although the prevalence of bacterial pathogens decreased significantly with azithromycin treatment, a significant change in the distribution of specific bacterial pathogens could not be demonstrated. Streptococcal resistance to azithromycin was found significantly more frequently after treatment. No change in the prevalence, distribution, or resistance pattern was found in the untreated control group.
CONCLUSION—Repeated mass treatment of trachoma endemic areas with oral azithromycin will have an effect on bacterial flora. However, further work needs to be done to determine if this will have any clinical relevance.



Full Text

The Full Text of this article is available as a PDF (76.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adegbola R. A., Mulholland E. K., Bailey R., Secka O., Sadiq T., Glasgow K., Mabey D. Effect of azithromycin on pharyngeal microflora. Pediatr Infect Dis J. 1995 Apr;14(4):335–337. doi: 10.1097/00006454-199504000-00024. [DOI] [PubMed] [Google Scholar]
  2. Bailey R. L., Arullendran P., Whittle H. C., Mabey D. C. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993 Aug 21;342(8869):453–456. doi: 10.1016/0140-6736(93)91591-9. [DOI] [PubMed] [Google Scholar]
  3. De Sole G. Elimination of trachoma: follow up. Br J Ophthalmol. 1998 May;82(5):590–590. doi: 10.1136/bjo.82.5.589b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Karcioglu Z. A., El-Yazigi A., Jabak M. H., Choudhury A. H., Ahmed W. S. Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels. Ophthalmology. 1998 Apr;105(4):658–661. doi: 10.1016/S0161-6420(98)94020-9. [DOI] [PubMed] [Google Scholar]
  5. Karma P., Pukander J., Penttilä M. Azithromycin concentrations in sinus fluid and mucosa after oral administration. Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):856–859. doi: 10.1007/BF01975841. [DOI] [PubMed] [Google Scholar]
  6. Leach A. J., Shelby-James T. M., Mayo M., Gratten M., Laming A. C., Currie B. J., Mathews J. D. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis. 1997 Mar;24(3):356–362. doi: 10.1093/clinids/24.3.356. [DOI] [PubMed] [Google Scholar]
  7. Lietman T. M., Dhital S. P., Dean D. Conjunctival impression cytology for vitamin A deficiency in the presence of infectious trachoma. Br J Ophthalmol. 1998 Oct;82(10):1139–1142. doi: 10.1136/bjo.82.10.1139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Peterson J., Treadway G. Impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis. 1998 Jan;26(1):248–249. doi: 10.1086/517045. [DOI] [PubMed] [Google Scholar]
  9. Seppälä H., Klaukka T., Vuopio-Varkila J., Muotiala A., Helenius H., Lager K., Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997 Aug 14;337(7):441–446. doi: 10.1056/NEJM199708143370701. [DOI] [PubMed] [Google Scholar]
  10. Stewart F. M., Antia R., Levin B. R., Lipsitch M., Mittler J. E. The population genetics of antibiotic resistance. II: Analytic theory for sustained populations of bacteria in a community of hosts. Theor Popul Biol. 1998 Apr;53(2):152–165. doi: 10.1006/tpbi.1997.1352. [DOI] [PubMed] [Google Scholar]
  11. Tabbara K. F., Abu-el-Asrar A., al-Omar O., Choudhury A. H., al-Faisal Z. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology. 1996 May;103(5):842–846. doi: 10.1016/s0161-6420(96)30605-2. [DOI] [PubMed] [Google Scholar]
  12. Tabbara K. F., al-Kharashi S. A., al-Mansouri S. M., al-Omar O. M., Cooper H., el-Asrar A. M., Foulds G. Ocular levels of azithromycin. Arch Ophthalmol. 1998 Dec;116(12):1625–1628. doi: 10.1001/archopht.116.12.1625. [DOI] [PubMed] [Google Scholar]
  13. Thylefors B. A global initiative for the elimination of avoidable blindness. Am J Ophthalmol. 1998 Jan;125(1):90–93. doi: 10.1016/s0002-9394(99)80239-6. [DOI] [PubMed] [Google Scholar]
  14. Thylefors B., Dawson C. R., Jones B. R., West S. K., Taylor H. R. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477–483. [PMC free article] [PubMed] [Google Scholar]
  15. Vaudaux B. P., Cherpillod J., Dayer P. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients. J Antimicrob Chemother. 1996 Jun;37 (Suppl 100):45–51. doi: 10.1093/jac/37.suppl_c.45. [DOI] [PubMed] [Google Scholar]
  16. Whitcher J. P., Dawson C. R., Messadi M., Daghfous T., Abdullah N. B., Triki F., Hoshiwara I. [Severe endemic trachoma in Tunisia: changes in ocular bacterial pathogens in children treated by the intermittent antibiotic regimen]. Rev Int Trach. 1974;51(4):49–58. [PubMed] [Google Scholar]
  17. Wildfeuer A., Laufen H., Zimmermann T. Distribution of orally administered azithromycin in various blood compartments. Int J Clin Pharmacol Ther. 1994 Jul;32(7):356–360. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES